TMPRSS2 and prostate neoplasm: The recent discoveries of the TMPRSS2-ERG rearrangement in subset of prostate cancer, with prevalence between 40–70% of all tumors, raised the question of the presence of this genetic aberration in more aggressive forms of prostate tumors.